BioSenic SA

Pre-Annual General Meeting Information • Aug 6, 2021

BONE THERAPEUTICS Limited liability company having made public appeal on savings Rue Auguste Piccard 37 6041 Gosselies RLE: Hainaut, Division Charleroi VAT: BE0882.015.654 (the "Company")

INFORMATION CONCERNING THE RIGHTS OF SHAREHOLDERS TO ASK QUESTIONS ON THE OCCASION OF THE EXTRAORDINARY GENERAL MEETING OF THE COMPANY TO BE HELD BE HELD BEFORE ONE OF THE NOTARIES OF BERQUIN NOTAIRES ON 23 AUGUST 2021 AS OF 11.00 AM (BELGIAN TIME) AT AVENUE LLOYD GEORGES, 1000 BRUSSELS

In accordance with article 7:139 of the Belgian Company and associations Code, shareholders have the right to ask questions in writing to the directors prior to the extraordinary general meeting that will be held on 23 August 2021.

The exercise of this right is subject to the fulfilment of the following two conditions:

• being a shareholder of the Company at the registration date (on 9 August 2021 at midnight); and

• having informed the Company of the intent to participate to the extraordinary general meeting, pursuant to the provisions set out in the convocation notice.

These questions can be submitted prior to the extraordinary general meeting by mail marked for the attention of Mr Jean-Philippe Bultot, Bone Therapeutics, rue Auguste Piccard 37, 6041 Gosselies, or by email to generalassembly@bonetherapeutics.com, or by fax to +32 71 12 10 01. They must be received by the Company on 17 August 2021 at 5.00 pm at the latest.

During the general meeting, the directors will answer the questions which have been raised by the shareholders (orally or in writing) on the items on the agenda, to the extent that the communication of data or facts is not potentially detrimental to the commercial interests of the Company or to the confidentiality undertakings of the Company or its directors.

The directors may give a global answer to different questions dealing with the same subject.